aDermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona
bDermatology Department, University Hospital Son Espases, Palma de Mallorca
cInstitut d’Investigacions Biomediques August Pi I Sunyer (IDIBAPS)
dBiomedical Research Networking Center on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain
Received 10 May 2022 Accepted 5 June 2022
Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.melanomaresearch.com.
Correspondence to Sebastian Podlipnik, MD, PhD, Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Villarroel 170. 08036, Barcelona, Spain, Tel: +34 93 2275400; fax: +34 93 2275438; e-mail: [email protected]
